Trial intelligence / Profile preview

Preemptive nalbuphine analgesia in laparoscopic cholecystectomy

ChiCTR-IPR-17011974Phase 4Not yet recruiting

Sponsor
Department of Anesthesiology, Chifeng Municipal Hospital
Start
Aug 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of nalbuphine in postoperative pain (3 arms), sponsored by Department of Anesthesiology, Chifeng Municipal Hospital. Primary endpoints: VAS score, interleukin-6 and 2 more. Planned start Aug 2017; status: not yet recruiting.

02

Drugs

nalbuphine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on ChiCTR-IPR-17011974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-17011974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call